Exogenous melatonin: quantitative enhancement in vivo of cells mediating non-specific immunity

scientific article published on 01 May 2000

Exogenous melatonin: quantitative enhancement in vivo of cells mediating non-specific immunity is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/S0165-5728(99)00271-4
P698PubMed publication ID10713348

P2093author name stringS C Miller
L Z Sun
N L Currier
P2860cites workMicroenvironmental organization and stromal cell associations of B lymphocyte precursor cells in mouse bone marrowQ34247644
Interleukin 2-induced proliferation of murine natural killer cells in vivoQ36350213
Effect of melatonin on activated macrophage TNF, IL-6, and reactive oxygen intermediates.Q41030130
Biological function and distribution of human interleukin-12 receptor beta chainQ41234457
Pharmacokinetics and oral bioavailability of exogenous melatonin in preclinical animal models and clinical implicationsQ41377025
Enkephalins in hematopoiesisQ41401203
Melatonin and the immune-hematopoietic system therapeutic and adverse pharmacological correlatesQ41574097
The photoperiod transducer melatonin and the immune-hematopoietic systemQ43070741
Pineal-opioid system interactions in the control of immunoinflammatory responsesQ44335582
kappa-Opioid receptors in marrow stroma mediate the hematopoietic effects of melatonin-induced opioid cytokinesQ44349058
Pharmacokinetics of melatonin in man after intravenous infusion and bolus injectionQ44902476
Specific binding of melatonin by purified cell nuclei from spleen and thymus of the rat.Q47848905
Exogenous melatonin enhances cell-mediated, but not humoral, immune function in adult male deer mice (Peromyscus maniculatus).Q48006782
Role of the pineal gland in immunity. Circadian synthesis and release of melatonin modulates the antibody response and antagonizes the immunosuppressive effect of corticosteroneQ48284579
Melatonin increases antigen presentation and amplifies specific and non specific signals for T-cell proliferationQ48294259
Circadian secretions of IL-2, IL-12, IL-6 and IL-10 in relation to the light/dark rhythm of the pineal hormone melatonin in healthy humansQ48365838
Adjuvant therapy with the pineal hormone melatonin in patients with lymph node relapse due to malignant melanomaQ48869346
Daily melatonin treatments regulate the circadian melatonin rhythm in the adult Djungarian hamsterQ49095349
Fluctuation of blood melatonin concentrations with age: result of changes in pineal melatonin secretion, body growth, and agingQ49158622
Pharmacokinetics of melatonin in human sexual maturation.Q51033617
Effect of melatonin and corticosteroid on in vitro cellular immune function in humans.Q52525855
Melatonin Administration Attenuates Depressed Immune Functions after Trauma-HemorrhageQ60156931
Small lymphocyte production and lymphoid cell proliferation in mouse bone marrowQ67014331
Population Dynamics of Natural Killer Cells in the Spleen and Bone Marrow of Normal and Leukemic Mice during in vivo Exposure to Interleukin-2Q67872220
The pineal control of aging. The effects of melatonin and pineal grafting on the survival of older miceQ67924582
Granulocyte-monocyte progenitor cells from human peripheral blood: modulation of growth in vitro by T lymphocytes and monocytesQ68090707
Enhancement of porcine natural killer cell activity by recombinant human and murine IL-12Q71530921
High-affinity binding of melatonin by human circulating T lymphocytes (CD4+)Q71737061
Effectiveness of immunotherapy in aged leukemic miceQ71738518
A glycolipid on the surface of mouse natural killer cellsQ72075905
Decline in natural killer cell-mediated immunosurveillance in aging mice--a consequence of reduced cell production and tumor binding capacityQ72414660
Immune responsiveness of splenocytes after chronic daily melatonin administration in male Syrian hamstersQ73626712
Long-term melatonin supplementation does not recover the impairment of natural killer cell activity and lymphocyte proliferation in aging miceQ73666802
A randomized study of chemotherapy with cisplatin plus etoposide versus chemoendocrine therapy with cisplatin, etoposide and the pineal hormone melatonin as a first-line treatment of advanced non-small cell lung cancer patients in a poor clinical stQ73901028
Modulation of cytokine production by dehydroepiandrosterone (DHEA) plus melatonin (MLT) supplementation of old miceQ74509476
Strain differences in natural killer cell-mediated immunity among mice: a possible mechanism for the low natural killer cell activity of A/J miceQ77150418
Melatonin: immune modulation of spleen cells in young, middle-aged and senescent miceQ77179770
Melatonin involvement in immunity and cancerQ93910071
P433issue2
P304page(s)101-108
P577publication date2000-05-01
P1433published inJournal of NeuroimmunologyQ15716691
P1476titleExogenous melatonin: quantitative enhancement in vivo of cells mediating non-specific immunity
P478volume104

Reverse relations

cites work (P2860)
Q22306049A Review of the Multiple Actions of Melatonin on the Immune System
Q36983795Are circadian rhythms the code of hypothalamic-immune communication? Insights from natural killer cells
Q38003366Beneficial actions of melatonin in the management of viral infections: a new use for this "molecular handyman"?
Q38453610Clinically feasible approaches to potentiating cancer cell-based immunotherapies.
Q42487556Effect of melatonin on phagocytic activity and intracellular free calcium concentration in testicular macrophages from normal and streptozotocin-induced diabetic rats
Q43242992Effect of melatonin on proliferation of neonatal cord blood mononuclear cells
Q45277536Effect of the preventive-therapeutic administration of melatonin on mammary tumour-bearing animals.
Q44044581Immune stimulation by exogenous melatonin during experimental endotoxemia
Q92815195Melatonin Modulates the Microenvironment of Glioblastoma Multiforme by Targeting Sirtuin 1
Q54660309Melatonin and Cancer Hallmarks.
Q33838766Melatonin and Fertoprotective Adjuvants: Prevention against Premature Ovarian Failure during Chemotherapy
Q41660894Melatonin and Hippo Pathway: Is There Existing Cross-Talk?
Q35666602Melatonin and viral infections
Q26751220Melatonin as a potential anticarcinogen for non-small-cell lung cancer
Q42484391Melatonin increases the survival time of animals with untreated mammary tumours: neuroendocrine stabilization.
Q25255508Melatonin, immune function and aging
Q37552036Melatonin--a pleiotropic molecule involved in pathophysiological processes following organ transplantation.
Q26801192Melatonin: a potential intervention for hepatic steatosis
Q36820644Melatonin: buffering the immune system
Q37007219Modulation by melatonin of the pathogenesis of inflammatory autoimmune diseases.
Q38076420Oxidative stress and immunosenescence: therapeutic effects of melatonin
Q37731345Parental Exposure to Dim Light at Night Prior to Mating Alters Offspring Adaptive Immunity
Q37097412Pharmacological advantages of melatonin in immunosenescence by improving activity of T lymphocytes
Q34285562Potential role of melatonin in prevention and treatment of oral carcinoma
Q38973727The Pathophysiologic Role of Disrupted Circadian and Neuroendocrine Rhythms in Breast Carcinogenesis
Q22306026The immunotherapeutic potential of melatonin
Q39310609The melatonin immunomodulatory actions in radiotherapy
Q36453337The role of melatonin in immuno-enhancement: potential application in cancer

Search more.